project id: TCGA-BRCA; case submitter id: TCGA-OL-A6VR; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.6; rna integrity number: 9.3; age at index: 48; days to birth: -17702; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1963; age at diagnosis: 17702; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage IA; ajcc pathologic t: T1b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1220.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 869; initial weight: 380.0; sample id: 9970c93c-8a6c-4e05-9d2f-4b6bdf087a98; sample submitter id: TCGA-OL-A6VR-01A; portion id: cc689b08-62d2-45f7-984b-17a5c3f806ce; portion submitter id: TCGA-OL-A6VR-01A-32; slide id: 4cd184cf-7f28-4878-ac5b-6f3e03ed660a; slide submitter id: TCGA-OL-A6VR-01A-03-TSC; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 0.0; percent necrosis: 2.0; percent neutrophil infiltration: 0.0; percent normal cells: 3.0; percent stromal cells: 75.0; percent tumor cells: 20.0; percent tumor nuclei: 75.0; section location: TOP;